probenecid has been researched along with novobiocin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (35.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 7 (41.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Benet, LZ; Brouwer, KL; Chu, X; Dahlin, A; Evers, R; Fischer, V; Giacomini, KM; Hillgren, KM; Hoffmaster, KA; Huang, SM; Ishikawa, T; Keppler, D; Kim, RB; Lee, CA; Niemi, M; Polli, JW; Sugiyama, Y; Swaan, PW; Tweedie, DJ; Ware, JA; Wright, SH; Yee, SW; Zamek-Gliszczynski, MJ; Zhang, L | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Christensen, LK; Hansen, JM | 1 |
| Celozzi, E; Miller, AK; Pelak, BA | 1 |
| Hällgren, R; Lindström, B; Odlind, B; Sohtell, M | 1 |
| Holmes, J; Sapeika, N; Zwarenstein, H | 1 |
| Arias, IM; Gatmaitan, Z; Levi, AJ | 1 |
| KOENIG, MG | 1 |
| Abaut, AY; Chevanne, F; Le Corre, P | 1 |
| Kaku, T; Kato, Y; Liu, K; Liu, Q; Meng, Q; Sun, H; Wang, C | 1 |
| Duan, L; Hu, W; Li, G; Sun, Y; Yan, Y; Zhao, B | 1 |
4 review(s) available for probenecid and novobiocin
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
Membrane transporters in drug development.
Topics: Animals; Computer Simulation; Decision Trees; Drug Approval; Drug Discovery; Drug Evaluation, Preclinical; Drug Interactions; Humans; Membrane Transport Proteins; Mice; Mice, Knockout; Prescription Drugs | 2010 |
Drug interactions with oral sulphonylurea hypoglycaemic drugs.
Topics: Allopurinol; Analgesics; Anticoagulants; Chloramphenicol; Chlorpropamide; Disulfiram; Drug Interactions; Ethanol; Glyburide; Humans; Hypoglycemic Agents; Hypolipidemic Agents; Kinetics; Monoamine Oxidase Inhibitors; Novobiocin; Phenylbutazone; Phenytoin; Probenecid; Propranolol; Rifampin; Sulfonamides; Sulfonylurea Compounds; Tolbutamide | 1977 |
THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS.
Topics: Animals; Anti-Bacterial Agents; Antitoxins; Bacitracin; Carrier State; Erythromycin; Furunculosis; Humans; Immune Sera; Immunotherapy, Active; Methicillin; Novobiocin; Osteomyelitis; Penicillins; Probenecid; Staphylococcal Infections; Toxicology; Toxins, Biological; Vancomycin | 1963 |
13 other study(ies) available for probenecid and novobiocin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
The enhancement of beta-lactam antibiotic therapy by novobiocin.
Topics: Animals; Cephaloridine; Cephalosporins; Drug Interactions; Female; Mice; Novobiocin; Penicillin G; Probenecid; Salmonella Infections, Animal | 1977 |
Is 125I iothalamate an ideal marker for glomerular filtration?
Topics: Animals; Chickens; Chromium Radioisotopes; Edetic Acid; Evaluation Studies as Topic; Glomerular Filtration Rate; Haplorhini; Humans; In Vitro Techniques; Iodine Radioisotopes; Iothalamic Acid; Kidney Function Tests; Kidney Tubules; Male; Novobiocin; Probenecid; Rabbits; Rats; Rats, Inbred Strains | 1985 |
Inhibitory effect of some quinoline, phthalazine, and coumarin derivatives on glucose-6-phosphate dehydrogenase in vitro.
Topics: Binding, Competitive; Chloroquine; Coumarins; Glucosephosphate Dehydrogenase; Heterocyclic Compounds; Hydralazine; Isoniazid; Novobiocin; Phenazines; Phenelzine; Phenylhydrazines; Probenecid; Pyridines; Quinacrine; Quinidine; Quinine; Quinolines; Sulfanilamides; Warfarin; Yeasts | 1973 |
Two hepatic cytoplasmic protein fractions, Y and Z, and their possible role in the hepatic uptake of bilirubin, sulfobromophthalein, and other anions.
Topics: Animals; Anti-Bacterial Agents; Bile Acids and Salts; Bilirubin; Butyrophenones; Chromatography, Gel; Coloring Agents; Cytoplasm; Female; Guinea Pigs; Haplorhini; Humans; Indocyanine Green; Iodipamide; Iodobenzenes; Liver; Male; Mice; Novobiocin; Probenecid; Protein Binding; Proteins; Rats; Sheep; Sulfobromophthalein | 1969 |
Influence of efflux transporters on liver, bile and brain disposition of amitriptyline in mice.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Brain; Cytochrome P-450 CYP2D6; Female; Injections, Intraperitoneal; Liver; Mice; Mice, Knockout; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Novobiocin; Probenecid; Quinidine; Tissue Distribution | 2009 |
Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters.
Topics: Animals; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Cephalosporins; Drug Interactions; Liver; Male; Novobiocin; Organic Anion Transporters, Sodium-Independent; Probenecid; Rats; Rats, Wistar; RNA, Messenger; Verapamil | 2010 |
Contribution of TRPV1 and multidrug resistance proteins in the permeation of capsaicin across different intestinal regions.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Capsaicin; In Vitro Techniques; Intestinal Absorption; Lower Gastrointestinal Tract; Male; Novobiocin; Permeability; Probenecid; Rats; Rats, Sprague-Dawley; Ruthenium Red; TRPV Cation Channels; Verapamil | 2013 |